Clinical trial
Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
NCT00004407 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 28, 1998
- Completion date
- March 31, 2000
- Enrollment
- 75
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.